Literature DB >> 9538004

Rhodopsin arginine-135 mutants are phosphorylated by rhodopsin kinase and bind arrestin in the absence of 11-cis-retinal.

W Shi1, C D Sports, D Raman, S Shirakawa, S Osawa, E R Weiss.   

Abstract

Arginine-135, located at the border between the third transmembrane domain and the second cytoplasmic loop of rhodopsin, is one of the most highly conserved amino acids in the family of G protein-coupled receptors. The effect of mutation at Arg-135 on the ability of rhodopsin to undergo desensitization was investigated. Four mutants, R135K, R135Q, R135A, and R135L, were examined for their ability to be phosphorylated by rhodopsin kinase, to bind arrestin, and to activate the rod cell G protein, transducin (Gt). All of the mutants were phosphorylated, bound arrestin, and were able to activate Gt when reconstituted with 11-cis-retinal. Surprisingly, several of the mutants could be phosphorylated by rhodopsin kinase and could bind arrestin in the absence of 11-cis-retinal but were not able to activate Gt. These observations represent the first demonstration of a mutant G protein-coupled receptor that assumes a conformation able to interact with its G protein-coupled receptor kinase and arrestin, but not with its G protein, in the absence of ligand.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538004     DOI: 10.1021/bi9731100

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  The arrestin-1 finger loop interacts with two distinct conformations of active rhodopsin.

Authors:  Matthias Elgeti; Roman Kazmin; Alexander S Rose; Michal Szczepek; Peter W Hildebrand; Franz J Bartl; Patrick Scheerer; Klaus Peter Hofmann
Journal:  J Biol Chem       Date:  2018-01-23       Impact factor: 5.157

2.  Light regulates the ciliary protein transport and outer segment disc renewal of mammalian photoreceptors.

Authors:  Ya-Chu Hsu; Jen-Zen Chuang; Ching-Hwa Sung
Journal:  Dev Cell       Date:  2015-03-23       Impact factor: 12.270

Review 3.  The cytoplasmic rhodopsin-protein interface: potential for drug discovery.

Authors:  Naveena Yanamala; Eric Gardner; Alec Riciutti; Judith Klein-Seetharaman
Journal:  Curr Drug Targets       Date:  2012-01       Impact factor: 3.465

4.  Identification of critical residues involved in ligand binding and G protein signaling in human somatostatin receptor subtype 2.

Authors:  Jesse J Parry; Ronald Chen; Rebecca Andrews; Kimberly A Lears; Buck E Rogers
Journal:  Endocrinology       Date:  2012-04-11       Impact factor: 4.736

Review 5.  Constitutively active rhodopsin and retinal disease.

Authors:  Paul Shin-Hyun Park
Journal:  Adv Pharmacol       Date:  2014

6.  Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes.

Authors:  Jen-Zen Chuang; Carrie Vega; Wenjin Jun; Ching-Hwa Sung
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  Visual arrestin interaction with clathrin adaptor AP-2 regulates photoreceptor survival in the vertebrate retina.

Authors:  Hormoz Moaven; Yukihiro Koike; Christine C Jao; Vsevolod V Gurevich; Ralf Langen; Jeannie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

8.  Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus.

Authors:  L S Barak; R H Oakley; S A Laporte; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

9.  Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.

Authors:  Kathryn L Chapman; Gemma K Kinsella; Alan Cox; Dan Donnelly; John B C Findlay
Journal:  J Mol Biol       Date:  2010-06-19       Impact factor: 5.469

10.  Hsp90 inhibition protects against inherited retinal degeneration.

Authors:  Mònica Aguilà; Dalila Bevilacqua; Caroline McCulley; Nele Schwarz; Dimitra Athanasiou; Naheed Kanuga; Sergey S Novoselov; Clemens A K Lange; Robin R Ali; James W Bainbridge; Carlos Gias; Peter J Coffey; Pere Garriga; Michael E Cheetham
Journal:  Hum Mol Genet       Date:  2013-12-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.